For individuals in the UK seeking evidence-based treatments for hair loss, the following options have established clinical support: Topical minoxidil: Licensed by the MHRA for androgenetic alopecia in both men and women (available as a 2% or 5% cutaneous solution or foam
This calibration is a clinical decision made at each session based on the current state of the skin, not a fixed protocol setting applied uniformly
A faint blue tint in the reconstituted GHK-Cu solution is characteristic of the copper(II) complex and directly indicates that the peptide is properly chelated with copper
Common GHK-Cu cycles : Standard cycle: 30 days on, 14 days off - repeat 23 cycles for skin goals Intensive cycle: 8 weeks on, 4 weeks off - preferred for hair and long healing protocols Maintenance cycle: 35 injections per week, 8 weeks on, 4 weeks off , indefinitely A 30-on / 14-off cycle means you're only using product about 68 % of the year - meaningful savings with no loss of results in our experience
GHK-Cu is studied in preclinical research on extracellular matrix remodeling, fibroblast and keratinocyte signaling, hair follicle research, dermal wound model studies, and copper-dependent enzyme research
formulation studies included microneedle and liposomal delivery
